Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837369 | PMC |
http://dx.doi.org/10.4103/ijo.IJO_2749_21 | DOI Listing |
JAMA Ophthalmol
June 2023
Department of Ocular Microbiology, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Indian J Ophthalmol
February 2023
Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Purpose: To describe the demographics, clinical profile, and outcomes of ocular siderosis in patients presenting to a multi-tier ophthalmology hospital network in India.
Methods: This cross-sectional and hospital-based study included 3,082,727 new patients who presented between August 2010 and December 2021. Patients with a clinical diagnosis of ocular siderosis in at least one eye were included.
Indian J Ophthalmol
December 2021
Department of Cataract and Refractive Lens Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.
Indian J Ophthalmol
November 2021
Department of Vitreo-Retina, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Expert Rev Clin Immunol
June 2019
a Department of Ophthalmology, University Medical Center Utrecht , Utrecht University, Utrecht , The Netherlands.
Uveitis is a sight-threatening eye inflammation and common manifestation of juvenile idiopathic arthritis (JIA). New biomarkers that can predict uveitis are needed to alleviate personalized clinical screening. In this review, we outline clinical and molecular risk factors for uveitis and discuss their putative biology and value for clinical practice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!